FIELD: medicine.
SUBSTANCE: present invention relates to the field of medicine, namely to a method for organ transplantation, including exposure of an organ to exogenous stem cells, wherein stem cells are human cells originating from bone marrow, non-embryonic, non-reproductive stem cells, expressing telomerase, have a normal karyotype, are not tumorigenic, wherein stem cells were subjected to at least 10-40 cell divisions in a culture before their exposure on organ, wherein the organ is subjected to the exposure to stem cells before the transplantation to a patient.
EFFECT: present invention provides for the reduction in harmful impacts of ischemia on an organ to be taken for transplantation or taken for transplantation.
16 cl, 7 dwg, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| IMPROVING ORGANS FOR TRANSPLANTATION | 2014 |
|
RU2665364C2 |
| OBTAINING PLURIPOTENT CELLS DE NOVO | 2013 |
|
RU2696071C2 |
| METHODS OF DERIVING DIFFERENTIATED CELLS FROM STEM CELLS | 2009 |
|
RU2576003C2 |
| METHOD FOR ISOLATION OF PLURIPOTENT STEM CELLS FROM UMBILICAL BLOOD EXPRESSING ZNF281 | 2010 |
|
RU2511417C2 |
| METHODS OF OBTAINMENT AND APPLICATION OF MULTIPOTENT CELL POPULATIONS | 2008 |
|
RU2535365C2 |
| HUMANIZED IL-6 AND IL-6 RECEPTOR | 2012 |
|
RU2751240C2 |
| METHODS RELATING TO PLURIPOTENT CELLS | 2015 |
|
RU2711942C2 |
| HUMANISED M-CSF MICE | 2012 |
|
RU2730643C2 |
| HUMANIZED M-CSF MICE | 2020 |
|
RU2819731C2 |
| METHODS FOR PRODUCING TISSUES | 2013 |
|
RU2733838C2 |
